Prodrug for tumor therapy
The world market for cancer diagnosis is estimated to be 3.5 billion dollars for 2010. Scientists at the University of Goettingen identified a new diagnostic tumor marker, which shows a general recognition of almost all cancers, an early detection of tumors and a very close causative link to cancer development. Thus, in the nearby future, this marker could also be used as a target for cancer therapy, as seen in first proof of principle experiments. The use in diagnostics of this new tumor marker would be ideal for first line of regular screening and for monitoring of a cancer therapy.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-152
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Superradiant atoms could push the boundaries of how precisely time can be measured
Superradiant atoms can help us measure time more precisely than ever. In a new study, researchers from the University of Copenhagen present a new method for measuring the time interval,…
Ion thermoelectric conversion devices for near room temperature
The electrode sheet of the thermoelectric device consists of ionic hydrogel, which is sandwiched between the electrodes to form, and the Prussian blue on the electrode undergoes a redox reaction…
Zap Energy achieves 37-million-degree temperatures in a compact device
New publication reports record electron temperatures for a small-scale, sheared-flow-stabilized Z-pinch fusion device. In the nine decades since humans first produced fusion reactions, only a few fusion technologies have demonstrated…